MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Redemption of marketable debt se...
Proceeds received in advance of ...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Purchase of marketable debt secu...
Accounts payable
Operating lease liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-25,346
-23,272
-18,106
-61,515
Depreciation and amortization
301
459
2,897
1,614
Stock-based compensation
5,528
1,210
2,082
9,719
Non-cash operating lease expense
239
228
219
605
Accretion of discount on marketable debt securities
194
239
375
2,585
Accounts receivable
0
-
-
-
Prepaid expenses and other current assets
-816
-694
-1,569
1,308
Accounts payable
-1,720
-5,896
1,129
4,897
Accrued expenses and other current liabilities
2,595
1,232
552
-3,375
Operating lease liabilities
-422
-396
-380
-1,070
Other
3
20
14
57
Net cash used in operating activities
-18,206
-26,000
-10,427
-53,075
Redemption of marketable debt securities
24,302
27,361
16,261
149,610
Purchase of marketable debt securities
3,001
10,992
0
107,005
Purchase of property and equipment
-
-
0
9
Net cash provided by investing activities
21,301
16,369
16,261
42,596
Proceeds received in advance of private placement
10,000
-
-
-
Proceeds from exercise of pre-funded warrants
0
-
-
-
Proceeds from issuance of common stock and pre-funded warrants in private placement, net of offering costs
-
0
0
2
Proceeds from the exercise of stock options
47
-
632
-
Proceeds from issuance of common stock pursuant to atm program, net of offering costs
-
-
0
-
Proceeds from issuance of common stock under espp
-
-
108
-
Tax withholding payments related to net settlement of restricted common stock and other awards
53
25
71
77
Net cash provided by (used in) financing activities
9,994
-25
669
-75
Net increase (decrease) in cash, cash equivalents and restricted cash
13,089
-9,656
6,503
-10,554
Cash, cash equivalents and restricted cash at beginning of year
7,238
16,894
10,391
20,945
Cash, cash equivalents and restricted cash at end of period
20,327
7,238
16,894
10,391
Cash and cash equivalents
18,855
-
-
-
Restricted cash
1,472
-
-
-
Total cash, cash equivalents and restricted cash shown in the statement of cash flows
20,327
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
PYXS Cash Flow Sankey Diagram
Sankey diagram visualizing PYXS cash flow for the period
Redemption of marketable
debt securities
$24,302K
Proceeds received in
advance of private...
$10,000K
Proceeds from the
exercise of stock options
$47K
Net cash provided by
investing activities
$21,301K
Net cash provided by
(used in) financing...
$9,994K
Canceled cashflow
$3,001K
Canceled cashflow
$53K
Net increase
(decrease) in cash, cash...
$13,089K
Canceled cashflow
$18,206K
Purchase of marketable
debt securities
$3,001K
Stock-based compensation
$5,528K
Accrued expenses and
other current...
$2,595K
Prepaid expenses and
other current assets
-$816K
Depreciation and
amortization
$301K
Non-cash operating lease
expense
$239K
Tax withholding
payments related to net...
$53K
Net cash used in
operating activities
-$18,206K
Canceled cashflow
$9,479K
Net loss
-$25,346K
Accounts payable
-$1,720K
Operating lease
liabilities
-$422K
Accretion of discount on
marketable debt securities
$194K
Other
$3K
Buy us a coffee
Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. (PYXS)